CXCR4, one of the most prevalent chemokine receptors, can promote the migration of many different types of cancer cells while it was significantly down‐regulated in the primary endometrial epithelial cells of adenomyosis after treated with mifepristone by analysis of RNA‐Seq data (Figure 2C). This evidence concerns the gene CXCR4 and cancer.